Publication | Closed Access

Quality by Design Approach for Developing Lipid-Based Nanoformulations of Gliclazide to Improve Oral Bioavailability and Anti-Diabetic Activity

Lipid PreparationNanomedicineDesign ApproachOral BioavailabilityEngineeringMedicineDiabetesLipid-based NanoformulationsNano-drug DeliveryBiomedical EngineeringInsulin DeliveryDrug Delivery SystemPharmacology